Sclerosis multiplex (SM): vizsgálatok itt: Finnország
9 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Tampere
- Életkor
- 18 év to 60 év
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - 2. fázisTaking peopleA Phase 2a Study of SUN-627 to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Impact on Measures of Neuroinflammation in the Central Nervous System in Participants With Non-Active Progressive Multiple Sclerosis (SPMS/PPMS)
- Where
- Turku
- Életkor
- 18 év and over
- People
- 30
- Run by
- Sundance Biosciences Inc.
See details and how to join2026-525817-29-00 · EU 2026-525817-29-00 - 2. fázisNot yet taking people in FinnországTARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis
- Where
- Turku
- Életkor
- 18 év and over
- People
- 61 worldwide
- Run by
- Oslo University Hospital HF
See details and how to join2025-522140-40-00 · EU 2025-522140-40-00 - 2. fázisTaking peopleA Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
- Where
- Turku
- Életkor
- 18 év to 64 év
- People
- 93 worldwide
- Run by
- Zenas Biopharma (USA) LLC
See details and how to join2024-512707-40-00 · EU 2024-512707-40-00 - 2. fázisTaking peopleA clinical proof-of-concept study to reduce smoldering inflammation in progressive MS
- Where
- Turku
- Életkor
- 18 év to 64 év
- People
- 34
- Run by
- University Of Turku
See details and how to join2024-517336-21-00 · EU 2024-517336-21-00 - 3. fázisTaking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Tampere
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - 2. fázisNot yet taking people in FinnországHydroxychloroquine in progressive MS
- Where
- Turku
- Életkor
- 18 év and over
- People
- 34
- Run by
- Varsinais-Suomen hyvinvointialue
See details and how to join2025-522573-11-00 · EU 2025-522573-11-00 - No phaseCsak meghívásosDoes Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients
- Where
- Turku
- Életkor
- 30 év to 80 év
- People
- 100
- Run by
- Turku University Hospital
See details and how to joinNCT04625049 - No phaseCsak meghívásosExploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging
- Where
- Turku
- Életkor
- 18 év to 80 év
- People
- 15
- Run by
- Turku University Hospital
See details and how to joinNCT06460077